Recombinant monoclonal antibodies are a cutting-edge class of antibodies engineered through genetic manipulation techniques. These antibodies are generated by cloning specific antibody-producing cells from immunized animals and incorporating their variable complementarity-determining regions (CDRs) into a recombinant expression system, typically mammalian cells or bacteria. These antibodies offer precision targeting, consistency and reproducibility, reduced immunogenicity, customization, and scalability, making them an invaluable tool for research, diagnostics, and therapeutics.
Recombinant monoclonal antibodies are widely used in immunohistochemistry (IHC) experiments to visualize and assess the distribution of specific antigens in tissues, aiding in disease diagnosis and research. These antibodies are also commonly employed in immunoprecipitation assays to isolate specific protein complexes for downstream analysis.
We offer a variety of recombinant mouse and rabbit monoclonals. With our state-of-the-art production capabilities, NeoBiotechnologies can manufacture recombinant antibodies at scale, ensuring a steady supply for research and clinical applications. Join us in unlocking the potential of our innovative recombinant antibody solutions.
